May 12, 2022Liked by Joey DeBruin

This process of owning the tokens of your competitors lead to win-wins for those playing the game, but bad outcomes for other stakeholders who are not in the game. In some fields e.g. scientific research this sort of collaborative outcome may be socially desirable, but in many other markets this kind of collusive behaviour leads to anti-competitive practices. If Doudna and Zhang pool their resources rather than starting competing firms using rival IP, they could drive up the price of liscensing CRISPR and make us all worse off. https://www.tse-fr.eu/sites/default/files/TSE/documents/sem2015/io/schmalz.pdf.pdf

Expand full comment